Journal of Experimental & Clinical Cancer Research (Jan 2023)
Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer
Abstract
No abstracts available.